The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 16,910 | 296,300 | SH | SOLE | 296,300 | 0 | 0 | ||
ABBOTT LABS | COM | 002824100 | 633 | 11,100 | SH | DFND | 1 | 0 | 11,100 | 0 | |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 598 | 10,000 | SH | DFND | 1 | 0 | 10,000 | 0 | |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 16,037 | 268,400 | SH | SOLE | 268,400 | 0 | 0 | ||
AETNA INC NEW | COM | 00817Y108 | 920 | 5,100 | SH | DFND | 1 | 0 | 5,100 | 0 | |
AETNA INC NEW | COM | 00817Y108 | 24,371 | 135,100 | SH | SOLE | 135,100 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 326 | 28,460 | SH | DFND | 1 | 0 | 28,460 | 0 | |
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 8,684 | 758,410 | SH | SOLE | 758,410 | 0 | 0 | ||
ALLERGAN PLC | 5.5% CNV PFD A | G0177J116 | 528 | 900 | PRN | DFND | 1 | 0 | 900 | 0 | |
ALLERGAN PLC | 5.5% CNV PFD A | G0177J116 | 14,129 | 24,100 | PRN | SOLE | 24,100 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 294 | 1,800 | SH | DFND | 1 | 0 | 1,800 | 0 | |
ALLERGAN PLC | SHS | G0177J108 | 7,705 | 47,100 | SH | SOLE | 47,100 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 232 | 2,100 | SH | DFND | 1 | 0 | 2,100 | 0 | |
AVEXIS INC | COM | 05366U100 | 6,198 | 56,000 | SH | SOLE | 56,000 | 0 | 0 | ||
CERNER CORP | COM | 156782104 | 411 | 6,100 | SH | DFND | 1 | 0 | 6,100 | 0 | |
CERNER CORP | COM | 156782104 | 10,978 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 6,891 | 266,377 | SH | SOLE | 266,377 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 258 | 9,968 | SH | DFND | 1 | 0 | 9,968 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 834 | 11,500 | SH | DFND | 1 | 0 | 11,500 | 0 | |
CVS HEALTH CORP | COM | 126650100 | 22,040 | 304,000 | SH | SOLE | 304,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 424 | 79,300 | SH | DFND | 1 | 0 | 79,300 | 0 | |
ENDOLOGIX INC | COM | 29266S106 | 11,326 | 2,116,925 | SH | SOLE | 2,116,925 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 42 | 200 | SH | Put | DFND | 1 | 0 | 200 | 0 |
EXACT SCIENCES CORP | COM | 30063P105 | 1,122 | 5,341 | SH | Put | SOLE | 5,341 | 0 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 82 | 13,627 | SH | DFND | 1 | 0 | 13,627 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,186 | 363,770 | SH | SOLE | 363,770 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 394 | 19,450 | SH | DFND | 1 | 0 | 19,450 | 0 | |
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 10,496 | 518,050 | SH | SOLE | 518,050 | 0 | 0 | ||
HEALTHSOUTH CORP | COM NEW | 421924309 | 208 | 4,200 | SH | DFND | 1 | 0 | 4,200 | 0 | |
HEALTHSOUTH CORP | COM NEW | 421924309 | 5,539 | 112,100 | SH | SOLE | 112,100 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 1,603 | 614,022 | SH | SOLE | 614,022 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 60 | 23,000 | SH | DFND | 1 | 0 | 23,000 | 0 | |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 784 | 52,300 | SH | DFND | 1 | 0 | 52,300 | 0 | |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 20,934 | 1,396,500 | SH | SOLE | 1,396,500 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 404 | 5,000 | SH | DFND | 1 | 0 | 5,000 | 0 | |
MEDTRONIC PLC | SHS | G5960L103 | 10,707 | 132,600 | SH | SOLE | 132,600 | 0 | 0 | ||
MIMEDX GROUP INC | COM | 602496101 | 332 | 26,300 | SH | DFND | 1 | 0 | 26,300 | 0 | |
MIMEDX GROUP INC | COM | 602496101 | 8,827 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
MYLAN N V | SHS EURO | N59465109 | 927 | 21,900 | SH | DFND | 1 | 0 | 21,900 | 0 | |
MYLAN N V | SHS EURO | N59465109 | 24,734 | 584,600 | SH | SOLE | 584,600 | 0 | 0 | ||
NOVARTIS A G | SPONSORED ADR | 66987V109 | 621 | 7,400 | SH | DFND | 1 | 0 | 7,400 | 0 | |
NOVARTIS A G | SPONSORED ADR | 66987V109 | 16,582 | 197,500 | SH | SOLE | 197,500 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 187 | 7,700 | SH | DFND | 1 | 0 | 7,700 | 0 | |
NXSTAGE MEDICAL INC | COM | 67072V103 | 4,979 | 205,500 | SH | SOLE | 205,500 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 135 | 6,500 | SH | DFND | 1 | 0 | 6,500 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,609 | 173,500 | SH | SOLE | 173,500 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 41,130 | 109,400 | SH | SOLE | 109,400 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,541 | 4,100 | SH | DFND | 1 | 0 | 4,100 | 0 | |
REVANCE THERAPEUTICS INC | COM | 761330109 | 304 | 8,500 | SH | DFND | 1 | 0 | 8,500 | 0 | |
REVANCE THERAPEUTICS INC | COM | 761330109 | 8,146 | 227,855 | SH | SOLE | 227,855 | 0 | 0 | ||
SANOFI | SPONSORED ADR | 80105N105 | 1,552 | 36,100 | SH | DFND | 1 | 0 | 36,100 | 0 | |
SANOFI | SPONSORED ADR | 80105N105 | 41,438 | 963,686 | SH | SOLE | 963,686 | 0 | 0 | ||
SELECT MED HLDGS CORP | COM | 81619Q105 | 312 | 17,700 | SH | DFND | 1 | 0 | 17,700 | 0 | |
SELECT MED HLDGS CORP | COM | 81619Q105 | 8,345 | 472,800 | SH | SOLE | 472,800 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 246 | 17,500 | SH | DFND | 1 | 0 | 17,500 | 0 | |
SIENTRA INC | COM | 82621J105 | 6,568 | 467,107 | SH | SOLE | 467,107 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 401 | 48,900 | SH | DFND | 1 | 0 | 48,900 | 0 | |
TG THERAPEUTICS INC | COM | 88322Q108 | 10,711 | 1,306,278 | SH | SOLE | 1,306,278 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 4,619 | 165,600 | SH | SOLE | 165,600 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 173 | 6,200 | SH | DFND | 1 | 0 | 6,200 | 0 |